Skip to main content
. 2020 Feb 26;40(12):2357–2365. doi: 10.1097/IAE.0000000000002761

Table 3.

Data of Four Infants Follow-up by Optos 200Tx

NO. Sex GA Birth Weight CGA Weight ROP (OD) ROP (OS) Therapy
1 Female 29 1,230 36 3,000 Stage 3 in Zone I, plus (+) Stage 3 in zone I Anti-VEGF therapy (ou) at 36 w
37 3,130 Vessels grew to Zone II Vessels grew to Zone II
2 Female 33 1,850 37 2,400 Stage 2 in Zone II Stage 2 in Zone II Anti-VEGF therapy (ou) at 35 w
38 2,770 Stage 2 in Zone II Stage 2 in Zone II
41 3,980 Stage 1 in Zone II Stage 2 in Zone II
3 Male 27 995 42 3,825 Stage 3 in Zone II Stage 2 in Zone II Laser photocoagulation (ou) at 42 w
46 5,740 After laser photocoagulation After laser photocoagulation
4 Female 31 1,550 38 2,980 Stage 3 in Zone II Stage 3 in Zone II Anti-VEGF therapy (ou) at 34 w
39 3,500 Stage 3 in Zone II Stage 3 in Zone II